University of Delaware
Newark, Delaware, 19713, United States
Location status: Recruiting
NCT Number: NCT06094816
The overall objective of this project is to identify the key salt-sensing regions of the brain and determine the underlying mechanism of sodium sensing. The investigators will assess how the brain responds to an acute increase of salt in the blood using MRI. This will be done during a 30-minute infusion of a saline solution containing 3% salt. One trial will be conducted with a salt sensing channel blocker and one trial without the salt sensing channel blocker. This will help to assess the role of a specific salt sensing channel in the brain. Salt sensitivity of BP will be assessed using 7-day dietary feeding where participants will be given food to consume for 7-days. Comparisons will be made between salt resistant (no change in blood pressure going from low to high salt diets) and salt sensitive adults (a change in blood pressure going from low to high salt diets). The investigators think the changes in MRI will be greater in salt sensitive compared to salt resistant subjects.
Interested in participating?
Request Info40 year–60 year
All sexes
Interventional
Phase 4
Newark, Delaware, 19713, United States
Location status: Recruiting
The ability of the brain to sense changing sodium levels in the blood is critical in mediating the neurohumoral responses to hypernatremia, however, the mechanisms underlying sodium sensing in humans is poorly understood. The purpose of this study is to identify key sodium-sensing regions of the human brain in middle-aged men and women with high blood pressure and determine if the Na-K-2Cl co-transporter (NKCC2) mediates the neurohumoral response to acute hypernatremia. The investigators plan on comparing these central sodium responses to acute hypernatremia between salt-sensitive and salt-resistant adults. In this randomized double-blinded crossover study subjects will have a 3% NaCl (hypertonic saline) infusion with or without NKCC2 antagonism (furosemide). Completion of this project will increase the understanding of blood pressure regulation, which has major public health implications.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The diuretic furosemide will be given during a 3% hypertonic saline infusion to examine blockade of the NKCC2.
Other names: Lasix
3% Hypertonic saline infusion to acutely increase sodium and osmolality
Time frame: 1 hour
Intensity of sodium sensing regions of the brain
Time frame: 1 hour
Systolic and Diastolic Blood pressure responses to hypertonic saline
Time frame: 1 hour
sympathetic bursts per minute
Contact information is provided by the study sponsor or research team.
Megan Wenner, PhD
CONTACT
Virginia Nuckols, PhD
CONTACT
University of Delaware
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07614724
Cardiovascular Diseases, Hypertension
Beijing, China
View Trial Details